Your browser doesn't support javascript.
loading
Cost-Effectiveness Modeling of Repetitive Transcranial Magnetic Stimulation Compared to Electroconvulsive Therapy for Treatment-Resistant Depression in Singapore.
Zhao, Ying Jiao; Tor, Phern Chern; Khoo, Ai Leng; Teng, Monica; Lim, Boon Peng; Mok, Yee Ming.
Afiliação
  • Zhao YJ; Pharmacy and Therapeutics Office, Group Corporate Development, National Healthcare Group, Singapore, Singapore.
  • Tor PC; Department of General Psychiatry 2, Institute of Mental Health, Mood Disorder Unit, Singapore, Singapore.
  • Khoo AL; Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Teng M; National University of Singapore, Singapore, Singapore.
  • Lim BP; Pharmacy and Therapeutics Office, Group Corporate Development, National Healthcare Group, Singapore, Singapore.
  • Mok YM; Pharmacy and Therapeutics Office, Group Corporate Development, National Healthcare Group, Singapore, Singapore.
Neuromodulation ; 21(4): 376-382, 2018 Jun.
Article em En | MEDLINE | ID: mdl-29143405
BACKGROUND: Compared to electroconvulsive therapy (ECT), the cost-effectiveness of repetitive transcranial magnetic stimulation (rTMS) in the management of treatment-resistant depression (TRD) remains unclear. OBJECTIVE/HYPOTHESIS: This study evaluated the cost-effectiveness of rTMS vs. ECT for TRD from Singapore societal perspective. METHODS: We constructed a Markov model to project the cost and benefit of rTMS compared with ECT over one year in patients with TRD. The relative treatment effects between rTMS and ECT were obtained from meta-analyses of published trials. The effectiveness and quality of life data for patients using ECT, resource use for TRD and their associated costs were derived from the national tertiary mental institution in Singapore. RESULTS: At one year, rTMS was cost-effective relative to ECT. The incremental cost-effectiveness ratio (ICER) associated with ECT was Singapore dollars (SGD) 311,024 per quality-adjusted life-year (QALY) gained. This exceeded the willingness-to-pay threshold of SGD 70,000 per QALY gained. A similar trend was observed for ICER per remission achieved (i.e., SGD 143,811 per remission achieved with ECT). In the subgroup analysis, rTMS was found to be less costly and more effective than ECT in nonpsychotic depressive patients. In the scenario analysis, ECT employed as an ambulatory service yielded a much smaller ICER (i.e., SGD 78,819 per QALY gained) compared to the standard inpatient setting. CONCLUSIONS: rTMS was a cost-effective treatment compared to ECT in TRD over one year. The cost-effectiveness of rTMS was attenuated when ECT was used in the outpatient setting.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Depressão / Eletroconvulsoterapia / Estimulação Magnética Transcraniana Tipo de estudo: Health_economic_evaluation / Systematic_reviews Limite: Female / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Depressão / Eletroconvulsoterapia / Estimulação Magnética Transcraniana Tipo de estudo: Health_economic_evaluation / Systematic_reviews Limite: Female / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article